A new generation of AD biomarkers: 2019 to 2021

J Hawksworth, E Fernandez, K Gevaert - Ageing research reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia and cases are rising
worldwide. The effort to fight this disease is hampered by a lack of disease-modifying …

Diverse pathways to neuronal necroptosis in Alzheimer's disease

A Jayaraman, R Reynolds - European Journal of Neuroscience, 2022 - Wiley Online Library
Necroptosis, or programmed necrosis, involves the kinase activity of receptor interacting
kinases 1 and 3, the activation of the pseudokinase mixed lineage kinase domain‐like and …

Nanosensor-Driven Detection of Neuron-Derived Exosomal Aβ42 with Graphene Electrolyte-Gated Transistor for Alzheimer's Disease Diagnosis

J Li, W Ni, D Jin, Y Yu, MM Xiao, ZY Zhang… - Analytical …, 2023 - ACS Publications
Blood-based tests have sparked tremendous attention in non-invasive early diagnosis of
Alzheimer's disease (AD), a most prevalent neurodegenerative malady worldwide. Despite …

Electroencephalography as a non-invasive biomarker of Alzheimer's disease: a forgotten candidate to substitute CSF molecules?

P Monllor, A Cervera-Ferri, MA Lloret, D Esteve… - International Journal of …, 2021 - mdpi.com
Biomarkers for disease diagnosis and prognosis are crucial in clinical practice. They should
be objective and quantifiable and respond to specific therapeutic interventions. Optimal …

Microglial transforming growth factor-Β signaling in Alzheimer's disease

N Vidovic, B Spittau - International Journal of Molecular Sciences, 2024 - mdpi.com
Novel technologies such as single-cell RNA and single-nucleus RNA sequencing have
shed new light on the complexity of different microglia populations in physiological and …

Dynamic changes in central and peripheral neuro-injury vs. neuroprotective serum markers in COVID-19 are modulated by different types of anti-viral treatments but …

K Laudanski, J Hajj, M Restrepo, K Siddiq, T Okeke… - Biomedicines, 2021 - mdpi.com
The balance between neurodegeneration, neuroinflammation, neuroprotection, and COVID-
19-directed therapy may underly the heterogeneity of SARS-CoV-2′ s neurological …

Effect of APOE ε4 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia …

MR Ben Khedher, M Haddad, D Laurin… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction The substantial link between apolipoprotein E (APOE) ε4 allele and oxidative
stress may underlie enhanced Alzheimer's disease (AD) risk. Here, we studied the impact of …

Neurodegenerative diseases reflect the reciprocal roles played by retroelements in regulating memory and immunity

A Herbert - Frontiers in Neuroscience, 2024 - frontiersin.org
Tetrapod endogenous retroelements (ERE) encode proteins that have been exapted to
perform many roles in development and also in innate immunity, including GAG (group …

Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer's disease diagnosis and therapeutic targets

L Huang, M Liu, Z Li, B Li, J Wang… - Neural Regeneration …, 2025 - journals.lww.com
Amyloid-beta clearance plays a key role in the pathogenesis of Alzheimer's disease.
However, the variation in functional proteins involved in amyloid-beta clearance and their …

[PDF][PDF] 双链RNA 依赖的蛋白激酶与阿尔茨海默病相关性研究进展

龚奕, 肖星洋, 胡有生, 谢义炜… - 中国医学科学院 …, 2024 - journal13.magtechjournal.com
阿尔茨海默病(AD) 是一种严重威胁人类健康的疾病, 也是引起人类死亡的三大因素之一.
双链RNA 依赖的蛋白激酶(PKR) 又称为前炎症细胞因子, 是人类先天免疫干扰素刺激因子之一 …